228 related articles for article (PubMed ID: 24692799)
1. Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study.
Angeli F; Repaci S; Borgioni C; Sardone M; Scotti A; Verdecchia P
Curr Ther Res Clin Exp; 2008 Jun; 69(3):207-20. PubMed ID: 24692799
[TBL] [Abstract][Full Text] [Related]
2. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension.
Palombo C; Malshi E; Morizzo C; Rakebrandt F; Corretti V; Santini F; Fraser AG; Kozakova M
Clin Ther; 2009 Dec; 31(12):2873-85. PubMed ID: 20110026
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study.
Rossetti G; Pizzocri S; Brasca F; Pozzi M; Beltrami LM; Bolla GB; Famiani R; Caimi B; Omboni S; Magrini F; Carugo S
Curr Ther Res Clin Exp; 2008 Jun; 69(3):192-206. PubMed ID: 24692798
[TBL] [Abstract][Full Text] [Related]
4. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
5. [Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy].
Wang HB; Shi Q; Zhang C
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):832-5. PubMed ID: 21600164
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Amlodipine/Lisinopril Fixed-Dose Combination on Severity of Left Ventricular Hypertrophy and Parameters of Myocardial Stiffness in Patients With Hypertension].
Ostroumova OD; Kochetkov AI
Kardiologiia; 2016 Dec; 56(11):27-37. PubMed ID: 28290816
[TBL] [Abstract][Full Text] [Related]
7. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
8. Effects of simvastatin on blood pressure in hypercholesterolemic patients: An open-label study in patients with hypertension or normotension.
Branchi A; Fiorenza AM; Torri A; Berra C; Colombo E; Rovellini A; Sommariva D
Curr Ther Res Clin Exp; 2004 May; 65(3):239-54. PubMed ID: 24672080
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: a prospective, randomized, open-label, blinded end point (PROBE), parallel-arm study.
Fogari R; Zoppi A; Mugellini A; Preti P; Destro M; Rinaldi A; Derosa G
Curr Ther Res Clin Exp; 2008 Feb; 69(1):1-15. PubMed ID: 24692778
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime. Barnidipine Study Group.
Imai Y; Abe K; Nishiyama A; Sekino M; Yoshinaga K
Am J Hypertens; 1997 Dec; 10(12 Pt 1):1415-9. PubMed ID: 9443779
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
Ibrahim MM; el-Boghdadly B; Zaghloul SS
J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of barnidipine hydrochloride in Thai patients with hypertension.
Buranakitjaroen P; Koanantakul B; Phoojaroenchanachai M; Chawantanpipat C
J Int Med Res; 2004; 32(2):185-200. PubMed ID: 15080023
[TBL] [Abstract][Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
15. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
[TBL] [Abstract][Full Text] [Related]
16. Effects of verapamil slow release plus trandolapril combination therapy on essential hypertension.
Derici U; Sindel S; Arinsoy T; Bali M; Goker B; Cemri M; Hasanoglu E
Curr Ther Res Clin Exp; 2003 Jan; 64(1):10-20. PubMed ID: 24944353
[TBL] [Abstract][Full Text] [Related]
17. Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.
Coca A; Sobrino J; Soler J; Módol J; Palos MA; Mínguez A; Esqúe J; Plana J; Cases M; Closas J; de la Sierra A
J Cardiovasc Pharmacol; 1997 Mar; 29(3):316-22. PubMed ID: 9125668
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
20. Effects of the fixed combination of manidipine plus delapril in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial.
Zoppi A; Mugellini A; Preti P; Rinaldi A; Celentano A; Arezzi E; Alberici M; Fogari R
Curr Ther Res Clin Exp; 2003 Jul; 64(7):422-33. PubMed ID: 24944393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
